Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 21 February 2022 Vol. No. 11; Issue No. 514

1. Shetty A, Chatterjee G, Rajpal S, Srivastava T, Gardi N, Mirgh S, Gokarn A, Punatar S, Shetty N, Joshi A, Nair S, Murthy V, Khattry N, Tembhare P, Dikshit R, Chaturvedi P, More A, Kamtalwar S, Chavan P, Bhat V, Patil A, Dhumal S, Bhat P, Subramanian P, Gujral S, Badwe R, Patkar N, Gupta S. (2022) "Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai". International Journal of Clinical Practice. 2022: 24490682.

2. Sharma A, Kumar A, Rashid M, Amnekar RV, Gupta S, Kaur J. (2022) A Phagosomally Expressed Gene, rv0428c, of Mycobacterium tuberculosis Demonstrates Acetyl Transferase Activity and Plays a Protective Role Under Stress Conditions. Protein Journal.

3. Achrekar MS. (2022).Enhanced recovery after surgery (ERAS) nursing program. Asia-Pacific Journal of Oncology Nursing.

Site of the Week

SwissTargetPrediction allows to estimate the most probable macromolecular targets of a small molecule, assumed as bioactive.

desktop Image
Interesting Reads

Schmidt R, Steinhart Z, Layeghi M, Freimer JW, Bueno R, Nguyen VQ, Blaeschke F, Ye CJ, Marson A. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science. 375(6580): eabj4008, 2022.

Legends of Science
Samir K Brahmachari Samir K Brahmachari

Samir K Brahmachari obtained his Ph.D. from the Indian Institute of Science, Bangalore, in 1978. He, along with his group, with the help of structural biology, computational genomics, and population-based polymorphism scanning, provided a structural framework for understanding the etiology of several neurological disorders. He also demonstrated the association of two genes with schizophrenia and Bipolar Disorder. He was elected member of the Human Genome Organization (1991); Indo-European Commission S&T steering committee. Dr. Brahmachari is the recipient of several prestigious awards like the Shanti Swarup Bhatnagar Award (1990); Prof. PK Bose Memorial Award (2004); HK Firodia Award (2007); Dr. RA Mashelkar Award (2007)

Mamannamana Vijayan Mamannamana Vijayan

Mamannamana Vijayan received his doctorate from the IISc, Bangalore, in 1967. His area of research was the structure and interactions of mycobacterial proteins. His studies provided insights into the relationship between hydration, molecular mobility, and protein action. His investigation determined the molecular recognition and aggregation patterns involving amino acids and peptides using an approach based on molecular complexes. He served in various capacities such as chairman of Molecular Biophysics Unit, Chairman of Division of Biological Sciences; Associate Director of IISC. Dr. Vijayan is a member of International Union of Crystallography (IUCr); the International Union of Pure & Applied Biophysics; the International Council for Science. He was awarded the Shanti Swarup Bhatnagar Award in 1985; Padma Shri in 2004.

Upcoming Events
ESMO Breast Cancer 2022

03-05 May, 2022

Virtual and In Person, at Berlin Germany.

The 2022 ASPHO( The American Society of Paediatric Hematology/ Oncology) Conference

04-07 May, 2022

At David L Lawrence Convention Centre, Pittsburgh.

The 3rd Immuno-Oncology World Congress

12-13 May, 2022

At Radisson Blue Scandinavia Hotel, Copenhagen, Denmark.

Do You Know?

In 1896, George T Beaston performed the first ovarian ablation for breast cancer treatment.

back Image
Cancer News
Identifying immune cells for personalized cancer immunotherapy

15 February 2022, National Institute of Health

The team identified gene-expression signatures in immune cells across different tumor types. They then looked at whether these signatures could predict which T cells recognize tumor neoantigens...

Researchers create personalized organoid models for rare spinal cancer

16 February 2022, Eurekalert

A new study adds to a growing body of evidence that organoids, lab grown collections of cells that mimic a patient’s tumor are a promising avenue for drug discovery to improve outcomes in patients with cancer...

Research reveals high-risk subtype of relapsed pediatric AML

17 February 2022, ScienceDaily

Scientists have found a previously overlooked mutation in a subtype of pediatric leukemia that has implications for identifying high-risk patients...

� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)